Avoro Capital Advisors LLC - 30 Jun 2025 SCHEDULE 13G/A Report for SOLENO THERAPEUTICS INC Common Stock, par value $0.001 per share (SLNO)

Filing Manager
Avoro Capital Advisors LLC
Reporting Manager
Avoro Capital Advisors LLC
Security
SOLENO THERAPEUTICS INC Common Stock, par value $0.001 per share
Symbol
SLNO
Shares outstanding
50,000,000 shares
Disclosed Ownership
2,050,000 shares
Ownership
4.1%
Form type
SCHEDULE 13G/A
Filing time
14 Aug 2025, 07:13:56 UTC
Date of event
30 Jun 2025
Next filing
17 Feb 2026
SEC
View on sec.gov

Reporting Managers (2)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Avoro Capital Advisors LLC 4.1% 2,050,000 2,050,000 0 /s/ Scott Epstein Scott Epstein, Chief Financial Officer & Chief Compliance Officer
Behzad Aghazadeh 4.1% 2,050,000 2,050,000 0 /s/ Behzad Aghazadeh Behzad Aghazadeh, Individually